截至2025年11月，Fluor股价飙升近50%，年初至今跌幅缩小至7%，这得益于其对NuScale核能的投资，但它仍是其ETF组中唯一表现不佳的股票。 Fluor’s stock soared nearly 50% by Nov. 2025, narrowing its YTD loss to 7%, fueled by its NuScale nuclear investment, but it remains the only underperformer in its ETF group.

Fluor股价在2025年11月暴涨近50%，此前4月暴跌40%，年初至今跌幅降至约7%，主要得益于其NuScale核反应堆投资带来的收益。 Fluor’s stock surged nearly 50% by November 2025 after a 40% April plunge, cutting its year-to-date loss to about 7%, driven by gains from its NuScale nuclear reactor investment. 尽管出现反弹,但该公司仍然是SPDR S & P MidCap 400 ETF集团本年度唯一的红交易集团,市场上限为68亿美元,对结果不一致、项目延误和执行风险一直存在关切。 Despite the rebound, the company remains the only one in its SPDR S&P MidCap 400 ETF group trading in the red for the year, with a $6.8 billion market cap and ongoing concerns over inconsistent results, project delays, and execution risks.